favipiravir-RTP
A nuceloside analogue in which the nucleobase is favipiravir. It is a RNA-dependent RNA polymerase inhibitor which exhibits anti-influenza and anti-coronaviral activities.
Classification
Chemical structure
| Molecular formula | C10H15FN3O15P3 |
|---|---|
| Charge | 0 |
| Average mass | 529.156 Da |
| Monoisotopic mass | 528.97 Da |
| Source | ChEBI |
| InChIKey | UUKPXXBDUCDZDA-KAFVXXCXSA-N |
NC(=O)c1nc(F)cn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c1=O
InChI=1S/C10H15FN3O15P3/c11-4-1-14(9(18)5(13-4)8(12)17)10-7(16)6(15)3(27-10)2-26-31(22,23)29-32(24,25)28-30(19,20)21/h1,3,6-7,10,15-16H,2H2,(H2,12,17)(H,22,23)(H,24,25)(H2,19,20,21)/t3-,6-,7-,10-/m1/s1
Also called
- 6-fluoro-4-[5-O-(hydroxy{[hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl)-β-D-ribofuranosyl]-3-oxo-3,4-dihydropyrazine-2-carboxamide
- 6-fluoro-3,4-dihydro-4-(5-O-(hydroxy((hydroxy(phosphonooxy)phosphinyl)oxy)phosphinyl)-β-D-ribofuranosyl)-3-oxo-2-pyrazinecarboxamide
- T-705 RTP
- T-705 ribosyl triphosphate
- T-705-4-ribofuranosyl-5'-triphosphate
- T-705RTP
- favipiravir riboside triphosphate
Cross-references
Activity roles
- anticoronaviral agent
CHEBI:149553 - antiviral drug
CHEBI:36044
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:170009 |
favipiravir-RTP | antibioticmech:chebi-1a84f4f03d |
2026-08-30 |
Molecular targets
SARS-CoV-2 RNA-dependent RNA polymerase catalytic site VIRAL_PROTEIN DIRECT_BINDING_TARGET
| Protein | Gene | Organism | Entry |
|---|---|---|---|
Replicase polyprotein 1ab UniProtKB:P0DTD1 |
rep | Severe acute respiratory syndrome coronavirus 2 NCBITaxon:2697049 |
REVIEWED |
Mechanism summary
- Mode of action
- VIRAL_POLYMERASE_INHIBITION microbial target
Record-level evidence
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
REVIEWED
Verified the exact triphosphate identity, structure, and antiviral class; curator-confirmed viral polymerase inhibition and added the direct SARS-CoV-2 RdRp catalytic-site target.
-
CURATED_UNIPROT_PROTEIN_EXAMPLES
Added curated SARS-CoV-2 replicase polyprotein 1ab (P0DTD1) UniProtKB protein example on the PRIMARY_LITERATURE SARS-CoV-2 RNA-dependent RNA polymerase catalytic site molecular target.